NICE has recommended an innovative daily tablet treatment shown to reduce symptoms and improve quality of life. Optimised final draft guidance published today recommends 12 SQ-HDM SLIT, also known as Acarizax and made by ALK-Abello, as an option for treating persistent moderate to severe house dust mite allergic rhinitis in people between 12 and 65-years-old. Around 13,000 people in England could benefit from this new therapy, the first treatment for persistent moderate to severe allergic rhinitis to be